As the world works to avoid spreading COVID-19, medical researchers are testing new ways to treat the virus. One method that's being tested is the use of convalescent plasma, the liquid part of blood that is collected from patients who have recovered from the novel coronavirus disease, COVID-19. Patients who survive COVID-19 develop antibodies, proteins that help fight the infection, in their blood. The use of these antibodies, which are found in the convalescent plasma, is being considered as a treatment for COVID-19; however, no official treatment for the virus has been found. Read more about plasma research and how you may be able to help from the Food and Drug Administration.
April 27, 2020 - 9:04am